You said: "Please explain how this company is a good investment"? Why not ask these people that own 72% of the outstanding stock. Do they know more than you and me? Institutional investors hold a majority ownership of SGYP through the 72.00% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Other industry. Last, during the quarter ended June 2017, these large investors purchased a net $9.2 million shares. Other institutional 48.90% Mutual fund holders 23.10% Individual stakeholders 11.42%